CAS 1031206-36-6

3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one

CAS : 1031206-36-6

Formule : C₁₈H₁₆O₄

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 296.3172

Ref: IN-DA0097FJ

(3E)-2,3-Dihydro-3-[(3-Hydroxy-4-Methoxyphenyl)Methylene]-6-Methyl-4H-1-Benzopyran-4-One

CAS : 1031206-36-6

(3E)-2,3-Dihydro-3-[(3-Hydroxy-4-Methoxyphenyl)Methylene]-6-Methyl-4H-1-Benzopyran-4-One

Degré de pureté : 97%

Masse moléculaire : 296.32g/mol

Ref: 54-OR1024162

IMS2186

CAS : 1031206-36-6

IMS2186

Degré de pureté : ≥98%

Masse moléculaire : 296.32g/mol

Ref: 54-BUP13519

IMS2186

CAS : 1031206-36-6

IMS2186: antichoroidal neovascularization reagent, arrests G2/M cancer phase, anti-proliferative, reduces eye leakage, non-toxic.

Formule : C₁₈H₁₆O₄

Degré de pureté : 99.96%

Couleur et forme : Soild

Masse moléculaire : 296.32

Ref: TM-T67746

IMS2186

CAS : 1031206-36-6

IMS2186 is a small molecule drug that inhibits the proliferation of cells and has an inhibitory effect on angiogenesis in vivo. This drug is also effective against inflammatory diseases, such as psoriasis and rheumatoid arthritis. IMS2186 has been shown to have a molecular pathogenesis of proliferative diabetic retinopathy. It inhibits the production of pro-inflammatory cytokines, growth factors, and pro-angiogenic proteins by targeting the cellular nucleus. IMS2186 may be able to prevent cancer cell growth and choroidal neovascularization in patients with age-related macular degeneration.

Formule : C₁₈H₁₆O₄

Degré de pureté : Min. 95%

Masse moléculaire : 296.32 g/mol

Ref: 3D-GRB20636